Dexlansoprazole

规格

138530-94-6CAS 号

688-930-9EC 号

2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazoleIUPAC 名称

C16H14F3N3O2S化学式

369.4 g/mol分子量

dexlansoprazole; (R)-Lansoprazole; 138530-94-6; Kapidex; dexilant; Dexilant Solutab; r-lansoprazole; TAK-390; TAK 390; Lansoprazole, (r)-; dexlansoprazol; T 168390; UYE4T5I70X; TAK-390MR; T-168390; NSC-758710; 2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole; 1H-Benzimidazole, 2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-; 2-[(R)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; (+)-2-((R)-((3-METHYL-4-(2,2,2-TRIFLUOROETHOXY)PYRIDIN-2-YL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE; dexlansoprazolum; R Lansoprazole; Lansoprazole r-; Lansoprazole, R; (+)-lansoprazole; Lansoprazole, R-; (+)-2-((R)-{(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl}sulfinyl)-1H-benzimidazole; 2-((R)-((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methane)sulfinyl)-1H-1,3-benzodiazole; 2-[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl]-1H-1,3-benzodiazole; R-Isomer Lansoprazole; RefChem:54964; TAK390MR; Dexlansoprazole delayed release; TAK390; A02BC06; DTXSID101044044; T168390; 2-((R)-(3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methanesulfinyl)-1H-1,3-benzodiazole; R-(+)-LANSOPRAZOLE; MFCD13196699; Lansoprazole r-form; (R)-2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole; C16H14F3N3O2S; 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole; (r)-(+)-lansoprazole; 2-[(R)-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole; Dexlansoprazole [USAN]; UNII-UYE4T5I70X; Dexlansoprazole (INN/USAN); Dexlansoprazole [USAN:INN]; (+)-lansoprazol; Dexilant (TN); (R)-2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl]sulfinyl]-1H-benzo[d]imidazole; Lansoprazole R-Isomer; SCHEMBL44975; DEXLANSOPRAZOLE [INN]; (R)-Lansoprazole (Standard); DEXLANSOPRAZOLE [VANDF]; GTPL5487; DEXLANSOPRAZOLE [MART.]; CHEMBL1201863; DEXLANSOPRAZOLE [WHO-DD]; SCHEMBL29353881; SCHEMBL29598842; SCHEMBL29750802; SCHEMBL29950208; LANSOPRAZOLE R-FORM [MI]; CHEBI:135931; HMS3652C14; HY-13662BR; BDBM50247930; DEXLANSOPRAZOLE [ORANGE BOOK]; EBC-28062; HY-13662B; s4099; AKOS025290765; CCG-213301; DB05351; FL24837; NSC 758710; PB33188; NCGC00386267-03; AC-26449; AS-18086; SY116177; SW219466-1; D08903; AB01563023_01; AB01563023_02; Q5268339; BRD-K05900209-001-01-8; BRD-K05900209-001-02-6; BRD-K05900209-001-03-4; Lansoprazole Working Standard (Secondary Reference Standard); (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole; (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole; (R)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole; (R)-(+)2-([3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl)-1H-benzimidazole; 2-[(R)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzoimidazole同义词